381 related articles for article (PubMed ID: 23453211)
1. L39. Fulminant ANCA vasculitis.
Karras A; Jacquot C; Thervet E
Presse Med; 2013 Apr; 42(4 Pt 2):607-9. PubMed ID: 23453211
[No Abstract] [Full Text] [Related]
2. L42. Morbidity in patients with ANCA-associated vasculitis.
Harper L
Presse Med; 2013 Apr; 42(4 Pt 2):612-6. PubMed ID: 23465300
[No Abstract] [Full Text] [Related]
3. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
[TBL] [Abstract][Full Text] [Related]
4. L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
Holle JU
Presse Med; 2013 Apr; 42(4 Pt 2):616-9. PubMed ID: 23481358
[No Abstract] [Full Text] [Related]
5. Granulomatous Vasculitis.
Sharma A; Dogra S; Sharma K
Dermatol Clin; 2015 Jul; 33(3):475-87. PubMed ID: 26143427
[TBL] [Abstract][Full Text] [Related]
6. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
Lally L; Spiera R
Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
[TBL] [Abstract][Full Text] [Related]
7. [Development of morbidity and mortality in ANCA-associated vasculitis].
Reinhold-Keller E; Moosig F
Z Rheumatol; 2011 Aug; 70(6):486-92. PubMed ID: 21779878
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and outcomes of ANCA-associated renal vasculitis.
Seck SM; Dussol B; Brunet P; Burtey S
Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):301-5. PubMed ID: 22382223
[TBL] [Abstract][Full Text] [Related]
9. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
[TBL] [Abstract][Full Text] [Related]
10. S1. Rituximab for ANCA-associated vasculitis: the experience in the United States.
Clain JM; Specks U
Presse Med; 2013 Apr; 42(4 Pt 2):530-2. PubMed ID: 23477713
[No Abstract] [Full Text] [Related]
11. Development and validation of case-finding algorithms for the identification of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in large healthcare administrative databases.
Sreih AG; Annapureddy N; Springer J; Casey G; Byram K; Cruz A; Estephan M; Frangiosa V; George MD; Liu M; Parker A; Sangani S; Sharim R; Merkel PA;
Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1368-1374. PubMed ID: 27804171
[TBL] [Abstract][Full Text] [Related]
12. Relapsing subarachnoid hemorrhage as a clinical manifestation in microscopic polyangiitis: a case report and literature review.
Xie J; Jia E; Wang S; Yu Y; Li Z; Zhang J; Li J
Clin Rheumatol; 2022 Oct; 41(10):3227-3235. PubMed ID: 35690669
[TBL] [Abstract][Full Text] [Related]
13. Severe cardiomyopathy revealing antineutrophil cytoplasmic antibodies-negative eosinophilic granulomatosis with polyangiitis.
Bouiller K; Samson M; Eicher JC; Audia S; Berthier S; Leguy V; Humbert O; Martin L; Lorgis L; Cottin Y; Bonnotte B; Lorcerie B
Intern Med J; 2014 Sep; 44(9):928-31. PubMed ID: 25201426
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary involvement in ANCA-associated vasculitis from the view of the pulmonologist.
Homma S; Suzuki A; Sato K
Clin Exp Nephrol; 2013 Oct; 17(5):667-671. PubMed ID: 23188194
[TBL] [Abstract][Full Text] [Related]
15. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis.
Klemmer PJ; Chalermskulrat W; Reif MS; Hogan SL; Henke DC; Falk RJ
Am J Kidney Dis; 2003 Dec; 42(6):1149-53. PubMed ID: 14655185
[TBL] [Abstract][Full Text] [Related]
16. ANCA-negative ANCA-associated vasculitis: pitfalls of the 'vasculitis screen'.
Cooke H; Wells M; Miller K; Medford ARL; Patel S
Clin Med (Lond); 2023 Nov; 23(6):630-632. PubMed ID: 38065599
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of ANCA-associated vascularitides].
Guillevin L; Pagnoux C
Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
[TBL] [Abstract][Full Text] [Related]
18. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):85-87. PubMed ID: 29185957
[TBL] [Abstract][Full Text] [Related]
19. Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia?
Duran E; Kilic L; Durhan G; Inkaya AÇ; Guven GS; Karakaya G; Ariyurek OM; Karadag O
Ann Rheum Dis; 2023 Apr; 82(4):e85. PubMed ID: 32709679
[No Abstract] [Full Text] [Related]
20. The initial predictors of death in 153 patients with ANCA-associated vasculitis in a single Korean centre.
Mun CH; Yoo J; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):65-72. PubMed ID: 29465370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
